追蹤
Nan Li
標題
引用次數
引用次數
年份
Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling
N Li, Y Xi, HN Tinsley, E Gurpinar, BD Gary, B Zhu, Y Li, X Chen, ...
Molecular cancer therapeutics 12 (9), 1848-1859, 2013
1362013
Persistent polyfunctional chimeric antigen receptor T cells that target glypican 3 eliminate orthotopic hepatocellular carcinomas in mice
D Li, N Li, YF Zhang, H Fu, M Feng, D Schneider, L Su, X Wu, J Zhou, ...
Gastroenterology 158 (8), 2250-2265. e20, 2020
1342020
Glypicans as cancer therapeutic targets
N Li, W Gao, YF Zhang, M Ho
Trends in cancer 4 (11), 741-754, 2018
1282018
Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastoma
N Li, H Fu, SM Hewitt, DS Dimitrov, M Ho
Proceedings of the National Academy of Sciences 114 (32), E6623-E6631, 2017
1262017
Colon tumor cell growth–inhibitory activity of sulindac sulfide and other nonsteroidal anti-inflammatory drugs is associated with phosphodiesterase 5 inhibition
HN Tinsley, BD Gary, J Thaiparambil, N Li, W Lu, Y Li, YY Maxuitenko, ...
Cancer Prevention Research 3 (10), 1303-1313, 2010
942010
A frizzled‐like cysteine‐rich domain in Glypican‐3 mediates Wnt binding and regulates hepatocellular carcinoma tumor growth in mice
N Li, L Wei, X Liu, H Bai, Y Ye, D Li, N Li, U Baxa, Q Wang, L Lv, Y Chen, ...
Hepatology 70 (4), 1231-1245, 2019
932019
Glypican‐3‐specific antibody drug conjugates targeting hepatocellular carcinoma
Y Fu, DJ Urban, RR Nani, YF Zhang, N Li, H Fu, H Shah, AP Gorka, ...
Hepatology 70 (2), 563-576, 2019
862019
A novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and β-catenin transcriptional activity
JD Whitt, N Li, HN Tinsley, X Chen, W Zhang, Y Li, BD Gary, AB Keeton, ...
Cancer prevention research 5 (6), 822-833, 2012
822012
Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and β-catenin-dependent TCF transcriptional activity
N Li, K Lee, Y Xi, B Zhu, BD Gary, V Ramírez-Alcántara, E Gurpinar, ...
Oncogene 34 (12), 1499-1509, 2015
722015
The role of glypicans in cancer progression and therapy
N Li, MR Spetz, M Ho
Journal of Histochemistry & Cytochemistry 68 (12), 841-862, 2020
642020
Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in Hepatocellular Carcinoma
L Sun, F Gao, Z Gao, L Ao, N Li, S Ma, M Jia, N Li, P Lu, B Sun, M Ho, ...
Journal for Immunotherapy of Cancer 9 (4), 2021
632021
β-catenin nuclear translocation in colorectal cancer cells is suppressed by PDE10A inhibition, cGMP elevation, and activation of PKG
K Lee, AS Lindsey, N Li, B Gary, J Andrews, AB Keeton, GA Piazza
Oncotarget 7 (5), 5353, 2016
612016
A novel sulindac derivative inhibits lung adenocarcinoma cell growth through suppression of Akt/mTOR signaling and induction of autophagy
E Gurpinar, WE Grizzle, JJ Shacka, BJ Mader, N Li, NA Piazza, S Russo, ...
Molecular cancer therapeutics 12 (5), 663-674, 2013
522013
Suppression of β-catenin/TCF transcriptional activity and colon tumor cell growth by dual inhibition of PDE5 and 10
N Li, X Chen, B Zhu, V Ramírez-Alcántara, JC Canzoneri, K Lee, S Sigler, ...
Oncotarget 6 (29), 27403, 2015
452015
CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice
N Li, MB Torres, MR Spetz, R Wang, L Peng, M Tian, CM Dower, ...
Cell Reports Medicine 2 (6), 2021
352021
Development of highly effective anti-mesothelin hYP218 chimeric antigen receptor T cells with increased tumor infiltration and persistence for treating solid tumors
S Tomar, J Zhang, M Khanal, J Hong, A Venugopalan, Q Jiang, ...
Molecular cancer therapeutics 21 (7), 1195-1206, 2022
332022
Phosphodiesterase 10A is overexpressed in lung tumor cells and inhibitors selectively suppress growth by blocking β-catenin and MAPK signaling
B Zhu, A Lindsey, N Li, K Lee, V Ramirez-Alcantara, JC Canzoneri, ...
Oncotarget 8 (41), 69264, 2017
332017
Novel non-cyclooxygenase inhibitory derivatives of naproxen for colorectal cancer chemoprevention
T Aboul-Fadl, SS Al-Hamad, K Lee, N Li, BD Gary, AB Keeton, GA Piazza, ...
Medicinal Chemistry Research 23, 4177-4188, 2014
242014
The IgG4 hinge with CD28 transmembrane domain improves VHH-based CAR T cells targeting a membrane-distal epitope of GPC1 in pancreatic cancer
N Li, A Quan, D Li, J Pan, H Ren, G Hoeltzel, N de Val, D Ashworth, W Ni, ...
Nature Communications 14 (1), 1986, 2023
202023
Advances in immunotherapeutic targets for childhood cancers: A focus on glypican-2 and B7-H3
N Li, MR Spetz, D Li, M Ho
Pharmacology & therapeutics 223, 107892, 2021
152021
系統目前無法執行作業,請稍後再試。
文章 1–20